Blood pressure reduction in hypertension--what is the optimal target value?
Januszewicz, Włodzimierz.; Januszewicz, A.
Kardiologia Polska 61(11): 505-510
2004
ISSN/ISBN: 0022-9032 PMID: 15883611 Document Number: 580254
Document emailed within 1 workday
Related Documents
Palatini, P.; Mormino, P.; Di Marco, A.; Libardoni, M.; Mos, L.; Munari, L.; Pessina, A.C.; Dal Palù, C. 1985: Ambulatory blood pressure versus casual pressure for the evaluation of target organ damage in hypertension: complications of hypertension Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 3(3): S425-S427Thalheimer, U.; Mela, M.; Patch, D.; Burroughs, A.K. 2004: Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence Gut 53(1): 143-148
Palatini; Canali; Dorigatti; Baccillieri; Giovinazzo; Roman; Mormino; Visentin; Berton; Catania; Gregori; Santonastaso; Piccolo; Garavelli; Pegoraro; D'Este; Maraglino; Martines; Businaro; Cignacco; Zanata; Gelisio; Mattarei; Biasion; Zonzin; Bortolazzi; Ferrarese; Mos; Ovan; Vriz; Graniero; Milani; Devenuto; Dal Follo M; Gatti; Camarotto; Stritoni; Perissinotto; Sanzuol; Cozzutti; Mognol; Pessina 1997: Target organ damage and ambulatory blood pressure in stage I hypertension. The Hypertension and Ambulatory Recording Venetia Study Blood Pressure Monitoring 2(2): 79-88
Falqui, V.; Viazzi, F.; Leoncini, G.; Ratto, E.; Parodi, A.; Conti, N.; Tomolillo, C.; Deferrari, G.; Pontremoli, R. 2007: Blood pressure load, vascular permeability and target organ damage in primary hypertension Journal of Nephrology 20(Suppl): S63-S67
Dmitrova, T.B.; Kotovskaia, I.V.; Kobalava, Z.D.; Moiseev, V.S. 2002: Possibilities of achieving target blood pressure in patients with essential hypertension in relation to renal functional status and age Terapevticheskii Arkhiv 74(12): 29-33
Guo, X-wei.; Wang, X-li-hong.; Gao, Z-ling. 2005: Effect of neuropeptide Y and neurotensin on diurnal rhythm of blood pressure and target organ damage for essential hypertension Zhonghua Xin Xue Guan Bing Za Zhi 33(11): 1006-1009
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071
Simmen, R.; Greminger, P.; Lüscher, T.; Lüscher-Mutter, B.; Siegenthaler, W.; Vetter, W. 1984: Long-term effect of weight reduction in patients with hypertension and normal blood pressure Schweizerische Rundschau für Medizin Praxis 73(25): 799-804
Divisón, J.A.; Puras, A.; Aguilera, M.; Sanchis, C.; Artigao, L.M.; Carrión, L.; Martínez Navarro, E.; García Gosálvez, F.; Carbayo, J. 2000: Home self-measurements of blood pressure and relationship with diagnosis of hypertension and target organ damage: comparative study with ambulatory monitoring Medicina Clinica 115(19): 730-735
Aoi, W.; Ueda, Y.; Tanigawa, M. 1992: Effect of weight loss on the reduction of blood pressure in obesity hypertension--hyperinsulinemia and renal sodium retention Nihon Jinzo Gakkai Shi 34(11): 1177-1182
Overlack, A.; Stumpe, K.O.; Zywzock, W.; Ressel, C.; Drück, F. 1979: Defect in kallikrein-kinin-system in essential hypertension and reduction of blood pressure by orally given kallikrein Advances in Experimental Medicine and Biology 120b: 539-547
Fagerberg, B.; Berglund, A.; Andersson, O.K.; Berglund, G. 1992: Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids Journal of Hypertension 10(9): 1053-1061
Heinzl, S. 2003: Lipid and blood pressure reduction for reduction of cardiovascular mortality Medizinische Monatsschrift für Pharmazeuten 26(6): 185
Krönig, B.; Dufey, K.; Meuter, K.; Wolff, H.P.; Knappen, F. 1976: Extent of the stress blood pressure in 40-65-years-old persons with normal blood pressure, in treated and nontreated patients with hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1278-1282
Thongsri, T. 2008: Effect and tolerability of felodipine ER (Feloten) in the treatment of hypertension assessed by office blood pressure and home blood pressure Journal of the Medical Association of Thailand 91(5): 633-640
Franz, I-Werner. 2006: Measure your patients blood pressure in all life situations. An elevated blood pressure in the office is not hypertension MMW Fortschritte der Medizin 148(37): 33
Staessen, J.A.; Celis, H.; Hond, E.Den.; Giot, C.; Leeman, M.; O'Brien, E.; Vandenhoven, G.; Fagard, R. 2002: Comparison of conventional and automated blood pressure measurements: interim analysis of the THOP trial. Treatment of Hypertension According to Home or Office Blood Pressure Blood Pressure Monitoring 7(1): 61-62
Braun, H.J.; Rabouw, H.; Werner, H.; van Montfrans, G.A.; de Stigter, C.; Zwinderman, A.H. 1999: Measurements of blood pressure with various techniques in daily practice: uncertainty in diagnosing office hypertension with short-term in-hospital registration of blood pressure Blood Pressure Monitoring 4(2): 59-64
Sugimoto, K.; Rakugi, H. 2013: Standard control for diabetes in older adults based on practice guidelines--the target values of blood glucose, blood pressure and lipids Nihon rinsho. Japanese journal of clinical medicine 71(11): 1913-1920
Zakovicova, E.; Charvat, J.; Mokra, D.; Svab, P.; Kvapil, M. 2014: The optimal control of blood glucose is associated with normal blood pressure 24 hours profile and prevention of the left ventricular remodeling in the patients with gestational diabetes mellitus Neuro Endocrinology Letters 35(4): 327-333